GGrantIndex
Sort

10,829 grants matching car t

The role of the intestinal microbiome in cancer immunotherapy

$1,014,601
Marcel R M Van Den Brink · Beckman Research Institute/City Of Hope · R35 · FY2024 · CA

Reprogramming of T cells for the Treatment of Melanoma

$1,014,415
Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2012 · CA

Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies

$1,013,623
Sarah Marie Hein · March Biosciences Inc · R44 · FY2024 · CA

A Novel Distracted Driving Prevention Tool

$1,009,674
Sara Seifert · Minnesota Healthsolutions Corporation · R44 · FY2021 · HD

Development of a treatment for the durable remission of HIV using autologous human CAR T cells that target B cell follicles

$1,009,537
Maria Constance Athanasiou · Marpam Pharma, Llc · R42 · FY2022 · AI

Nanosystems Biology Cancer Center

$1,009,425
James R. Heath · California Institute Of Technology · U54 · FY2017 · CA

Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.

$1,008,900
David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA

Towards targeting the lymphoma microenvironment

$1,008,898
Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA

SMART: A Social and Mobile Weight Control Program for Young Adults

$1,007,229
Kevin Patrick · University Of California, San Diego · U01 · FY2012 · HL

Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH

$1,006,870
Fakhrul Ahsan · Vascular Biosciences · R42 · FY2022 · HL

Analysis and Modulation of Virus-Host Interaction in Infections of the Liver

$1,005,702
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients

$1,005,131
Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2025 · CA

HIV-Receptor Interactions and Related Anti-HIV Strategies

$1,004,403
Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Adaptable and scalable electroporation for cellular therapy

$1,002,657
Harold G Craighead · Cytequest, Inc. · R44 · FY2024 · GM

Clinical production of viral vectors for cancer gene therapy

$1,001,150
Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Determining computational principles governing neural circuits responsible for feedback and movement control of D. melanogaster flight

$1,000,728
Itai Cohen · Cornell University · RF1 · FY2020 · NS

A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressed

$1,000,449
Maria Constance Athanasiou · Marpam Pharma, Llc · R42 · FY2024 · AI

Collaborative Research: Transferable, Hierarchical, Expressive, Optimal, Robust, Interpretable Networks

$1,000,000
Sosale S Sastry · University Of California-Berkeley · · FY2020 · MPS

BIGDATA:F: Statistical and Computational Optimal Transport for Geometric Data Analysis

$1,000,000
Justin M Solomon · Massachusetts Institute Of Technology · · FY2018 · CSE

SBIR Phase II: Utilizing Carbon Dioxide (CO2) as a Feedstock to Produce Commodity Chemicals

$1,000,000
Chern-Hooi Lim · New Iridium · · FY2023 · TIP

CPS: Medium: GOALI: Real-Time Computer Vision in Autonomous Vehicles: Real Fast Isn't Good Enough

$1,000,000
James H Anderson · University Of North Carolina At Chapel Hill · · FY2019 · CSE

Guide RNA manufacturing capabilities for platform in vivo base editing therapies for metabolic liver diseases

$1,000,000
William H. Peranteau · Children'S Hosp Of Philadelphia · U19 · FY2025 · NS

Collaborative Research: DMREF: Establishing a molecular interaction framework to design and predict modern polymer semiconductor assembly

$1,000,000
Natalie Stingelin · Georgia Tech Research Corporation · · FY2023 · MPS

CPS: Frontier: Collaborative Research: Correct-by-Design Control Software Synthesis for Highly Dynamic Systems

$1,000,000
Paulo Tabuada · University Of California-Los Angeles · · FY2013 · CSE

Tailored NRT Integrated with Smartphone Behavioral Support

$1,000,000
Alan Joel Levy · Chrono Therapeutics, Inc. · R44 · FY2017 · CA